Earth Science Tech reports FY 2023: retired 81% of liabilities, eliminated convertible notes

Earth Science Tech, Inc.

Retired ~$1.5M (81%) of liabilities; controlling shareholder converted $385K notes to equity, eliminating all convertible debt.
Completed mergers with RxCompoundStore and Peaks Curative as wholly owned subsidiaries.
RxCompound obtained dispensing licenses in 7 new states; sterile compounding lab began operations in May 2023.
CEO expects significant revenue and free cash flow growth in Q1 ending June 30, 2023; no further financing needed absent acquisitions.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.92

Earth Science Tech, Inc. reported financial results for the year ended March 31, 2023.

Period: the year ended March 31, 2023
Result: reported results

Exact text from the filing

On June 20, 2023 Earth Science Tech, Inc., a Florida corporation (the “Company”) filed its 10-K reporting its financial results for the year ended March 31, 2023.

View on SEC.gov

334 earnings releases filed in the last 30 days. Browse all earnings releases →

Earth Science Tech, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-23-021789

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.